XML 57 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Preferred Shares
Common Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Distributions in Excess of Retained Earnings
Total Shareholders' Equity
Non-Controlling Interests
Preferred stock, beginning balance (in shares) at Dec. 31, 2018   20,400,000            
Common stock, beginning balance (in shares) at Dec. 31, 2018     130,311,289          
Beginning balance at Dec. 31, 2018 $ 3,769,930 $ 204 $ 1,303 $ 4,065,804 $ 1,330 $ (308,806) $ 3,759,835 $ 10,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares, offering costs (275)     (275)     (275)  
Issuance of common shares for Board of Trustees compensation (in shares)     25,282          
Issuance of common shares for Board of Trustees compensation 740   $ 1 739     740  
Repurchase of common shares (in shares)     (126,681)          
Repurchase of common shares     $ (1) (4,008)     (4,009)  
Share-based compensation (in shares)     275,066          
Share-based compensation 1,848   $ 2 1,570     1,572 276
Distribution on common shares/units (49,912)         (49,771) (49,771) (141)
Distribution on preferred shares (8,139)         (8,139) (8,139)  
Other comprehensive income (loss):                
Unrealized gain (loss) on derivative instruments (9,039)       (9,039)   (9,039)  
Net income (loss) 5,655         5,635 5,635 20
Preferred stock, ending balance (in shares) at Mar. 31, 2019   20,400,000            
Common stock, ending balance (in shares) at Mar. 31, 2019     130,484,956          
Ending balance at Mar. 31, 2019 $ 3,706,799 $ 204 $ 1,305 4,063,830 (7,709) (361,081) 3,696,549 10,250
Preferred stock, beginning balance (in shares) at Dec. 31, 2019 20,400,000 20,400,000            
Common stock, beginning balance (in shares) at Dec. 31, 2019 130,484,956   130,484,956          
Beginning balance at Dec. 31, 2019 $ 3,631,936 $ 204 $ 1,305 4,069,410 (24,715) (424,996) 3,621,208 10,728
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares, offering costs (85)     (85)     (85)  
Issuance of common shares for Board of Trustees compensation (in shares)     23,528          
Issuance of common shares for Board of Trustees compensation 637   $ 1 636     637  
Repurchase of common shares (in shares)     (47,507)          
Repurchase of common shares (1,255)   $ (1) (1,254)     (1,255)  
Share-based compensation (in shares)     102,249          
Share-based compensation 17,637   $ 1 7,020     7,021 10,616
Distribution on common shares/units (768)         (764) (764) (4)
Distribution on preferred shares (8,139)         (8,139) (8,139)  
Other comprehensive income (loss):                
Unrealized gain (loss) on derivative instruments (54,265)       (54,265)   (54,265)  
Net income (loss) $ 42,068         41,949 41,949 119
Preferred stock, ending balance (in shares) at Mar. 31, 2020 20,400,000 20,400,000            
Common stock, ending balance (in shares) at Mar. 31, 2020 130,563,226   130,563,226          
Ending balance at Mar. 31, 2020 $ 3,627,766 $ 204 $ 1,306 $ 4,075,727 $ (78,980) $ (391,950) $ 3,606,307 $ 21,459